Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis

Seth Flaxman(Imperial College London), Rupert Bourne(Anglia Ruskin University), Serge Resnikoff(Brien Holden Vision Institute), Peter Ackland(International Agency for the Prevention of Blindness), Tasanee Braithwaite(Moorfields Eye Hospital NHS Foundation Trust), Maria Vittoria Cicinelli(San Raffaele University of Rome), Aditi Das(York Hospital), Jost B. Jonas(Heidelberg University), Jill Keeffe(L V Prasad Eye Institute), John H. Kempen(Massachusetts Eye and Ear Infirmary), Janet L Leasher(Nova Southeastern University), Hans Limburg, Kovin Naidoo(Brien Holden Vision Institute), Konrad Pesudovs(Flinders University), Alex Silvester, Gretchen A Stevens(World Health Organization), Nina Tahhan(Brien Holden Vision Institute), Tien Yin Wong(National University of Singapore), Hugh R. Taylor(The University of Melbourne), Rupert Bourne(Anglia Ruskin University), Peter Ackland(International Agency for the Prevention of Blindness), Aries Arditi, Yaniv Barkana, Banu Bozkurt, Tasanee Braithwaite(Moorfields Eye Hospital NHS Foundation Trust), Alain M. Bron(Université de Bourgogne), Donald L. Budenz, Feng Cai, Robert J. Casson, Usha Chakravarthy, Jaewan Choi, Maria Vittoria Cicinelli(San Raffaele University of Rome), Nathan Congdon, Reza Dana, Rakhi Dandona, Lalit Dandona, Aditi Das(York Hospital), Iva Dekaris, Monte A. Del Monte, Jenny P Deva, Laura E. Dreer, Leon B. Ellwein, Marcela Frazier, Kevin D. Frick, David S. Friedman, João M. Furtado, Hua Gao, Gus Gazzard, Ronnie George, Stephen Gichuhi, Víctor García González, Billy R. Hammond, M. Elizabeth Hartnett, Minguang He(World Health Organization), J. Fielding Hejtmancik, Flávio Hirai, John J. Huang(Massachusetts Eye and Ear Infirmary), April Ingram, Jonathan Javitt, Jost B. Jonas(Heidelberg University), Charlotte E. Joslin, Jill Keeffe(L V Prasad Eye Institute), John H. Kempen(Massachusetts Eye and Ear Infirmary), Moncef Khairallah, Rohit Khanna, Judy Kim, George Ι. Lambrou, Van Charles Lansingh, Paolo Lanzetta, Janet L Leasher(Nova Southeastern University), Jennifer I. Lim, Hans Limburg, Kaweh Mansouri, Anu Mathew, Alan R. Morse, Beatriz Muñoz, David C. Musch, Kovin Naidoo(Brien Holden Vision Institute), Vinay Nangia, M. Palaiou(San Raffaele University of Rome), Maurízio Battaglia Parodi, Fernando Yaacov Peña, Konrad Pesudovs(Flinders University), Tünde Pető, Harry A. Quigley, Murugesan Raju, Pradeep Ramulu, Zane Rankin, Serge Resnikoff(Brien Holden Vision Institute), Dana Reza, Alan L. Robin, Luca Rossetti, Jinan Saaddine, Mya Sandar, Janet B. Serle(Nova Southeastern University), Tueng T. Shen, Rajesh Shetty, Pamela C. Sieving, Juan Carlos Silva, Alex Silvester, Rita S. Sitorus, Dwight Stambolian, Gretchen A Stevens(World Health Organization), Hugh R. Taylor(The University of Melbourne), Jaime Tejedor, James M. Tielsch, Miltiadis K. Tsilimbaris, Jan van Meurs(Nova Southeastern University), Rohit Varma, Gianni Virgili, Ya Xing Wang, Ningli Wang, Sheila K. West, Peter Wiedemann(International Agency for the Prevention of Blindness), Tien Yin Wong(National University of Singapore), Richard Wormald, Yingfeng Zheng
The Lancet Global Health
October 13, 2017
Cited by 3,405Open Access
Full Text

Abstract

BACKGROUND: Contemporary data for causes of vision impairment and blindness form an important basis of recommendations in public health policies. Refreshment of the Global Vision Database with recently published data sources permitted modelling of cause of vision loss data from 1990 to 2015, further disaggregation by cause, and forecasts to 2020. METHODS: In this systematic review and meta-analysis, we analysed published and unpublished population-based data for the causes of vision impairment and blindness from 1980 to 2014. We identified population-based studies published before July 8, 2014, by searching online databases with no language restrictions (MEDLINE from Jan 1, 1946, and Embase from Jan 1, 1974, and the WHO Library Database). We fitted a series of regression models to estimate the proportion of moderate or severe vision impairment (defined as presenting visual acuity of <6/18 but ≥3/60 in the better eye) and blindness (presenting visual acuity of <3/60 in the better eye) by cause, age, region, and year. FINDINGS: We identified 288 studies of 3 983 541 participants contributing data from 98 countries. Among the global population with moderate or severe vision impairment in 2015 (216·6 million [80% uncertainty interval 98·5 million to 359·1 million]), the leading causes were uncorrected refractive error (116·3 million [49·4 million to 202·1 million]), cataract (52·6 million [18·2 million to 109·6 million]), age-related macular degeneration (8·4 million [0·9 million to 29·5 million]), glaucoma (4·0 million [0·6 million to 13·3 million]), and diabetic retinopathy (2·6 million [0·2 million to 9·9 million]). Among the global population who were blind in 2015 (36·0 million [12·9 million to 65·4 million]), the leading causes were cataract (12·6 million [3·4 million to 28·7 million]), uncorrected refractive error (7·4 million [2·4 million to 14·8 million]), and glaucoma (2·9 million [0·4 million to 9·9 million]). By 2020, among the global population with moderate or severe vision impairment (237·1 million [101·5 million to 399·0 million]), the number of people affected by uncorrected refractive error is anticipated to rise to 127·7 million (51·0 million to 225·3 million), by cataract to 57·1 million (17·9 million to 124·1 million), by age-related macular degeneration to 8·8 million (0·8 million to 32·1 million), by glaucoma to 4·5 million (0·5 million to 15·4 million), and by diabetic retinopathy to 3·2 million (0·2 million to 12·9 million). By 2020, among the global population who are blind (38·5 million [13·2 million to 70·9 million]), the number of patients blind because of cataract is anticipated to rise to 13·4 million (3·3 million to 31·6 million), because of uncorrected refractive error to 8·0 million (2·5 million to 16·3 million), and because of glaucoma to 3·2 million (0·4 million to 11·0 million). Cataract and uncorrected refractive error combined contributed to 55% of blindness and 77% of vision impairment in adults aged 50 years and older in 2015. World regions varied markedly in the causes of blindness and vision impairment in this age group, with a low prevalence of cataract (<22% for blindness and 14·1-15·9% for vision impairment) and a high prevalence of age-related macular degeneration (>14% of blindness) as causes in the high-income subregions. Blindness and vision impairment at all ages in 2015 due to diabetic retinopathy (odds ratio 2·52 [1·48-3·73]) and cataract (1·21 [1·17-1·25]) were more common among women than among men, whereas blindness and vision impairment due to glaucoma (0·71 [0·57-0·86]) and corneal opacity (0·54 [0·43-0·66]) were more common among men than among women, with no sex difference related to age-related macular degeneration (0·91 [0·70-1·14]). INTERPRETATION: The number of people affected by the common causes of vision loss has increased substantially as the population increases and ages. Preventable vision loss due to cataract (reversible with surgery) and refractive error (reversible with spectacle correction) continue to cause most cases of blindness and moderate or severe vision impairment in adults aged 50 years and older. A large scale-up of eye care provision to cope with the increasing numbers is needed to address avoidable vision loss. FUNDING: Brien Holden Vision Institute.


Related Papers

No related papers found

Powered by citation graph analysis